References
- Berry, S. M., Carlin, B. P., Lee, J. J., Muller, P. (2010). Bayesian Adaptive Methods for Clinical Trials. London, UK: Chapman and Hall/CRC Press.
- Dignam, J. J., Bryant, J., Wieand, H. S. (2006). Early stopping of cancer clinical trials. In Crowley, J., Ankerst, D. P. (eds.), Handbook of Statistics in Clinical Oncology, 2nd ed., London, UK: Taylor & Francis, pp. 227–246.
- Gasparini, M., Di Scala, L., Bretz, F., Racine-Poon, A. (2013). Predictive probability of success in clinical drug development. Epidemiology Biostatistics and Public Health 10(1):1–14.
- Jennison, C., Turnbull, B. W. (1997). Group-sequential analysis incorporating covariate information. JASA 92(440):1330–1340.
- Jennison, C., Turnbull, B. W. (1999). Group Sequential Methods with Applications to Clinical Trials. London, UK: Chapman & Hall/CRC.
- Johns, D., Anderson, J. (1999). Use of predictive probabilities in phase II and phase III clinical trials. Journal of Biopharmaceutical Statistics. 9(1):67–79.
- Pampallona, S., Tsiatis, A. A. (1994). Group sequential designs for one sided and two sided hypothesis testing with promise for early stopping in favor of null hypothesis. Journal of Statistics Planning and Inference 42:19–35.
- Scharfstein, D. O., Tsiatis, A. A., Robins, J. M. (1997). Semiparametric efficiency and its implication on the design and analysis of group sequential studies. JASA 92:1342–1350.
- Spiegelhalter, D. J., Freeman, L. S. (1986). A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. Statistics in Medicine 5:1–13.
- Spiegelhalter, D. J., Freedman, L. S., Blackburn, P. R. (1986). Monitoring clinical trials: Conditional or predictive power. Controlled Clinical Trials 7:8–17.
- Tang, Z., Dey, J. (2011). Bayesian PPOS Design for Clinical Trials. PaSIPHIC Annual Meeting.
- Wang, Y., Fu, H., Kulkarni, P., Kaiser, C. (2013). Evaluating and utilizing probability of study success in clinical development. Clinical Trials 10:407–413.